Citation Impact 2023
Journal Impact Factor: 4.4
5-year Journal Impact Factor: 4.9
Source Normalized Impact per Paper (SNIP): 1.294
SCImago Journal Rank (SJR): 1.518
Speed 2024
Submission to first editorial decision (median days): 11
Submission to acceptance (median days): 118
Usage 2024
Downloads: 3,978,337
Altmetric mentions: 1,452
Articles
Page 156 of 159
-
Citation: Arthritis Research & Therapy 2000 2:66807
-
Role of TGF? in immune homeostasis
Citation: Arthritis Research & Therapy 2000 3:66805 -
A novel regulator of Th1 differentiation
Citation: Arthritis Research & Therapy 2000 3:66804 -
Autoantigenic B cells and their role in lymphomagenesis in Sjogren's disease
Citation: Arthritis Research & Therapy 2000 3:66803 -
TALL-1 and autoimmunity
Citation: Arthritis Research & Therapy 2000 3:66802 -
Association of MHC and rheumatoid arthritis: Why is rheumatoid arthritis associated with the MHC genetic region? An introduction
Citation: Arthritis Research & Therapy 2000 2:203 -
Association of MHC and rheumatoid arthritis: HLA-DR4 and rheumatoid arthritis - studies in mice and men
Inherited susceptibility to rheumatoid arthritis (RA) is associated with the DRB1 genes encoding the human leukocyte antigen (HLA)-DR4 and HLA-DR1 molecules. Transgenic mice expressing these major histocompati...
Citation: Arthritis Research & Therapy 2000 2:208 -
Association of MHC and rheumatoid arthritis: HLA polymorphisms in phenotypic variants of rheumatoid arthritis
Genes in the human leukocyte antigen (HLA) region remain the most powerful disease risk genes in rheumatoid arthritis (RA). Several allelic variants of HLA-DRB1 genes have been associated with RA, supporting a...
Citation: Arthritis Research & Therapy 2000 2:212 -
Integrin aV?3 is important for bone resorption
Citation: Arthritis Research & Therapy 2000 3:66801 -
TRAIL inhibits autoimmune inflammation
Citation: Arthritis Research & Therapy 2000 3:66800 -
Rat genetic marker database
Citation: Arthritis Research & Therapy 2000 2:0009 -
A mechanism for anti-chondrogenic effects of IL1
Citation: Arthritis Research & Therapy 2000 3:66799 -
Association of MHC and rheumatoid arthritis: Association of RA with HLA-DR4 - the role of repertoire selection
Most patients with rheumatoid arthritis (RA) express HLA-DR4, HLA-DR1 or HLA-DR10. These alleles share a common amino acid motif in their third hypervariable regions: the shared epitope. In normals and patient...
Citation: Arthritis Research & Therapy 2000 2:217 -
Association of MHC and rheumatoid arthritis: Regulatory role of HLA class II molecules in animal models of RA - studies on transgenic/knockout mice
Human leucocyte antigen (HLA) class II molecules have been shown to be associated with predisposition to rheumatoid arthritis (RA). We generated HLA-DR and DQ transgenic mice that lacked endogenous class II mo...
Citation: Arthritis Research & Therapy 2000 2:205 -
Macrophages in rheumatoid arthritis
The abundance and activation of macrophages in the inflamed synovial membrane/pannus significantly correlates with the severity of rheumatoid arthritis (RA). Although unlikely to be the 'initiators' of RA (if ...
Citation: Arthritis Research & Therapy 2000 2:189 -
Deficiency of Il-1ra may predispose to development of arthritis
Citation: Arthritis Research & Therapy 2000 3:66798 -
The effect of age on proteoglycan aggregation in human cartilage
Citation: Arthritis Research & Therapy 2000 3:66797 -
ODF/RANKL independent osteoclast differentiation
Citation: Arthritis Research & Therapy 2000 3:66796 -
Rheumatoid arthritis viewed using a headache paradigm
Results and new hypotheses in animal models often stimulate development of new paradigms in how we view rheumatoid arthritis (RA). The complexity of RA does, however, eventually lead to the rejection of these ...
Citation: Arthritis Research & Therapy 2000 2:169 -
Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset
An inception cohort of 238 patients having peripheral joint synovitis of less than 12 months duration was evaluated clinically and followed prospectively for 1 year to determine the clinical significance of a ...
Citation: Arthritis Research & Therapy 2000 2:236 -
p53 in rheumatoid arthritis: friend or foe?
The knowledge of transcription factors and proto-oncogenes has influenced the understanding of cell regulation, cell
Citation: Arthritis Research & Therapy 2000 2:175 -
Post-transcriptional regulation of pro-inflammatory gene expression
The cytokine tumour necrosis factor (TNF)α is a vital mediator of the innate immune response, and a pleiotropic regulator of cellular function. Its involvement in rheumatoid arthritis is illustrated by the cli...
Citation: Arthritis Research & Therapy 2000 2:172 -
Cell fate decision: T-helper 1 and 2 subsets in immune responses
After activation CD4+ helper T cells differentiate into T-helper (Th) 1 or Th2 effector cells. These two subsets are characterized by their distinct cytokine expression pattern and the immune function they mediat...
Citation: Arthritis Research & Therapy 2000 2:179 -
Anti-TNF-α therapy as a clinical intervention for periprosthetic osteolysis
Aseptic loosening of total joint arthroplastics due to periprosthetic osteolysis is a frequent cause of implant failure. The absence of clinical interventions to arrest or prevent this complication limits the ...
Citation: Arthritis Research & Therapy 2000 2:165 -
Autoimmunity in BAFF transgenic mice
Citation: Arthritis Research & Therapy 2000 3:66795 -
OPGL - the link between T cell activation and bone loss
Citation: Arthritis Research & Therapy 2000 3:66794 -
Treatment of autoimmune disease with allogeneic BMT
Citation: Arthritis Research & Therapy 2000 2:66793 -
Role for IL-18 in rheumatoid arthritis
Citation: Arthritis Research & Therapy 2000 3:66792 -
Role of ERK and NF-?B pathways in osteoclasts
Citation: Arthritis Research & Therapy 2000 3:66791 -
Correlation of sacroiliitis inflammatory change with MRI
Citation: Arthritis Research & Therapy 2000 3:66790 -
Development of memory
Citation: Arthritis Research & Therapy 2000 2:66789 -
metaRegister of Controlled Trials
Citation: Arthritis Research & Therapy 2000 2:0011 -
NFATp represses chondrogenesis
Citation: Arthritis Research & Therapy 2000 3:66788 -
Apoptosis and p53 expression in rat adjuvant arthritis
The kinetics of apoptosis and the apoptosis-regulating gene p53 in adjuvant arthritis (AA) were investigated to assess the value of the AA rat model for testing apoptosis-inducing therapies. Very few terminal deo...
Citation: Arthritis Research & Therapy 2000 2:229 -
PPAR? negatively regulates T cell function
Citation: Arthritis Research & Therapy 2000 3:66787 -
Information and services for the arthritis community
Citation: Arthritis Research & Therapy 2000 2:0007 -
Acute-phase serum amyloid A production by rheumatoid arthritis synovial tissue
Acute-phase serum amyloid A (A-SAA) is a major component of the acute-phase response. A sustained acute-phase response in rheumatoid arthritis (RA) is associated with increased joint damage. A-SAA mRNA express...
Citation: Arthritis Research & Therapy 2000 2:142 -
B cells in rheumatoid arthritis
Normally the immune response is restricted to the peripheral secondary lymphoid organs. However, additional ectopic lymphoid tissue may develop at chronic sites of inflammation. In the synovium of rheumatoid a...
Citation: Arthritis Research & Therapy 2000 2:126 -
Risk for rheumatic disease in relation to ethnicity and admixture
Risk of systemic lupus erythematosus (SLE) is high in west Africans compared with Europeans, and risk of rheumatoid arthritis (RA) is high in Native Americans compared with Europeans. These differences are not...
Citation: Arthritis Research & Therapy 2000 2:115 -
A revival of the B cell paradigm for rheumatoid arthritis pathogenesis?
Dominant paradigms for the understanding of rheumatoid arthritis (RA) pathogenesis have changed over the years. A predominant role of B lymphocytes, and perhaps of the rheumatoid factor they produced, was init...
Citation: Arthritis Research & Therapy 2000 2:90 -
The role of VEGF in bone formation
Citation: Arthritis Research & Therapy 2000 2:66786 -
Mice deficient in secreted IgM develop autoimmune disease
Citation: Arthritis Research & Therapy 2000 3:66785 -
CD25+ CD4+immunoregulatory T cells
Citation: Arthritis Research & Therapy 2000 3:66784 -
CD40 ligand blockade
Citation: Arthritis Research & Therapy 2000 3:66783 -
T cell gene expression profiles
Citation: Arthritis Research & Therapy 2000 3:66782 -
What can we do about osteoarthritis?
Osteoarthritis is complex in genetics, pathogenesis, monitoring and treatment. Current treatment of osteoarthritis does not influence progression. Much could be gained by more effective 'low-tech-low-cost' tre...
Citation: Arthritis Research & Therapy 2000 2:95 -
Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis
Serum and synovial tissue expression of the matrix metalloproteinase (MMP)-2 and -9 and their molecular regulators, MMP-14 and TIMP-2 was examined in 28 patients with inflammatory early synovitis and 4 healthy...
Citation: Arthritis Research & Therapy 2000 2:145 -
Death, autoantigen modifications, and tolerance
Autoantibodies present in the serum of patients with a variety of inflammatory diseases have proven useful as diagnostic markers and as probes with which to elucidate biochemical and signaling pathways. The me...
Citation: Arthritis Research & Therapy 2000 2:101 -
A new model for rheumatoid arthritis?
A chance observation has led to the development of a new murine model for inflammatory arthritis. Arthritis is induced, and transferred, by T-cell-dependent antibodies to glucose-6-phosphate isomerase. This en...
Citation: Arthritis Research & Therapy 2000 2:85 -
Association of MHC Class II and CD40
Citation: Arthritis Research & Therapy 2000 3:66781